These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 3136397)

  • 21. Transcriptional regulation of c-Jun expression during late G1/S in normal human cells is lost in human tumor cells.
    Carter R; Yumet G; Peña A; Soprano DR; Soprano KJ
    Oncogene; 1994 Sep; 9(9):2675-82. PubMed ID: 8058331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
    Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
    Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.
    Lallemand D; Spyrou G; Yaniv M; Pfarr CM
    Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cell cycle duration by c-myc levels.
    Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
    Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth-regulated expression of FKBP-59 immunophilin in normal and transformed fibroblastic cells.
    Doucet-Brutin S; Renoir M; Le Gallic L; Vincent S; Marty L; Fort P
    Exp Cell Res; 1995 Sep; 220(1):152-60. PubMed ID: 7664831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes.
    Sabourin LA; Hawley RG
    J Cell Physiol; 1990 Dec; 145(3):564-74. PubMed ID: 1703172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
    Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
    J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo protein-DNA interactions at the c-jun promoter in quiescent and serum-stimulated fibroblasts.
    Rozek D; Pfeifer GP
    J Cell Biochem; 1995 Mar; 57(3):479-87. PubMed ID: 7768982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
    Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
    Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
    Vial E; Perez S; Castellazzi M
    Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of anisomycin on activation of early response genes c-fos, c-jun, Egr-1 in cells transformed by E1A and cHa-ras oncogenes].
    Kukushkin AN; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 2005; 39(1):80-8. PubMed ID: 15773551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle analysis of Krox-20, c-fos, and JE expression in proliferating NIH3T3 fibroblasts.
    Cortner J; Farnham PJ
    Cell Growth Differ; 1991 Sep; 2(9):465-73. PubMed ID: 1721529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and expression of the rat c-jun messenger RNA: tissue distribution and increase during chemical hepatocarcinogenesis.
    Sakai M; Okuda A; Hatayama I; Sato K; Nishi S; Muramatsu M
    Cancer Res; 1989 Oct; 49(20):5633-7. PubMed ID: 2507134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proto-oncogene mRNA levels and activities of multiple transcription factors in C3H 10T 1/2 murine embryonic fibroblasts exposed to 835.62 and 847.74 MHz cellular phone communication frequency radiation.
    Goswami PC; Albee LD; Parsian AJ; Baty JD; Moros EG; Pickard WF; Roti Roti JL; Hunt CR
    Radiat Res; 1999 Mar; 151(3):300-9. PubMed ID: 10073668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
    Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4.
    Shimizu M; Nomura Y; Suzuki H; Ichikawa E; Takeuchi A; Suzuki M; Nakamura T; Nakajima T; Oda K
    Exp Cell Res; 1998 Feb; 239(1):93-103. PubMed ID: 9511728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
    Kataoka K; Noda M; Nishizawa M
    Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.